These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 14987051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
    Perron V, Rabouin D, Asselin E, Parent S, C-Gaudreault R, Bérubé G.
    Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
    [Abstract] [Full Text] [Related]

  • 3. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N, Purohit A, Fernandez-Gacio A, Jones GB, Ray R.
    J Cell Biochem; 2006 Oct 15; 99(3):966-77. PubMed ID: 16741968
    [Abstract] [Full Text] [Related]

  • 4. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar 15; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P, Fortin S, Leblanc V, Parent S, Asselin É, Bérubé G.
    Steroids; 2012 Sep 15; 77(11):1113-22. PubMed ID: 22801351
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
    Devraj R, Barrett JF, Fernandez JA, Katzenellenbogen JA, Cushman M.
    J Med Chem; 1996 Aug 16; 39(17):3367-74. PubMed ID: 8765520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis of unique 17beta-estradiol homo-dimers, estrogen receptors binding affinity evaluation and cytocidal activity on breast, intestinal and skin cancer cell lines.
    Bérubé G, Rabouin D, Perron V, N'Zemba B, Gaudreault RC, Parent S, Asselin E.
    Steroids; 2006 Oct 16; 71(10):911-21. PubMed ID: 16914177
    [Abstract] [Full Text] [Related]

  • 11. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ, Liu ZJ, Shimoi K, Zhu BT.
    Cancer Res; 2005 Jan 15; 65(2):387-93. PubMed ID: 15695378
    [Abstract] [Full Text] [Related]

  • 12. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, Shirakawa Y, Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y.
    Int J Oncol; 2009 Feb 15; 34(2):313-9. PubMed ID: 19148464
    [Abstract] [Full Text] [Related]

  • 13. 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.
    Rachner TD, Schoppet M, Niebergall U, Hofbauer LC.
    Biochem Biophys Res Commun; 2008 Apr 11; 368(3):736-41. PubMed ID: 18252198
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
    Kingston DG, Chaudhary AG, Chordia MD, Gharpure M, Gunatilaka AA, Higgs PI, Rimoldi JM, Samala L, Jagtap PG, Giannakakou P, Jiang YQ, Lin CM, Hamel E, Long BH, Fairchild CR, Johnston KA.
    J Med Chem; 1998 Sep 10; 41(19):3715-26. PubMed ID: 9733497
    [Abstract] [Full Text] [Related]

  • 15. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer.
    Sutherland TE, Schuliga M, Harris T, Eckhardt BL, Anderson RL, Quan L, Stewart AG.
    Clin Cancer Res; 2005 Mar 01; 11(5):1722-32. PubMed ID: 15755993
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 18. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A, Fujii T, Yamaguchi M, Kage M, Shirouzu K, Oie S, Basaki Y, Ono M, Yamana H, Kuwano M.
    Clin Cancer Res; 2006 May 15; 12(10):3010-8. PubMed ID: 16707596
    [Abstract] [Full Text] [Related]

  • 19. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM, Mendorou C, Haroutounian SA, Alexis MN.
    Steroids; 2006 Mar 15; 71(3):249-55. PubMed ID: 16360721
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
    Burke PJ, Koch TH.
    J Med Chem; 2004 Feb 26; 47(5):1193-206. PubMed ID: 14971899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.